IQ Endoscopes Ltd, a medical device company creating a single use endoscopy platform to enable the early diagnosis of gastro-intestinal diseases, has announced the appointment of Martin Frost CBE as Chairman, effective from 1st July 2022. Martin is a highly recognised senior figure from the medical device industry, following his role as founding CEO of CMR Surgical. In 2019 he was awarded UK Entrepreneur of the Year in the Industry Disruptor category and Executive of the Year 2019 by Medtech Insight before receiving a CBE in 2020.
Since its successful seed funding round in July 2020 and subsequent Series A raise in September 2021, IQ Endoscopes Ltd has undergone rapid acceleration and achievement towards its aim of launching a new disruptive, single use endoscopic technology platform. Founding Chairman Dr Patrick Ward-Booth is stepping down from the position to allow Martin to use the knowledge and experience he possesses to guide the company through its next phase of growth. Patrick will remain on the Board of Directors as both a Founder and Clinical Director.
Dr Patrick Ward-Booth says “I am excited about this next chapter for the company and am confident that Martin is the best person to take us to the next level. It’s amazing to think that this all started as an idea and is now in a position to bring in people that are going to make this idea a reality. I am looking forward to focusing my efforts on our increased clinical activity and continuing to be involved in the future success of the company.”
Martin Frost CBE says “I’m really looking forward to working with Patrick, Matt Ginn CEO, and the whole team to bring IQ Endoscope’s flexible single use endoscopic platform to the market, to help address a large and growing clinical need and to build a significant devices business from the UK.”
Source: IQ Endoscopes